BlackburnDFDobsonRTBlackburnJLWilsonTW. Cardiovascular morbidity associated with nonadherence to statin therapy. Pharmacotherapy2005;25(8):1035–43.
3.
ShalevVChodickGSilberH. Continuation of statin treatment and all-cause mortality: a population-based cohort study. Arch Intern Med2009;169(3):260–8.
4.
Van WijkBLGKlungelOHHeerdinkERde BoerA. Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review. Ann Pharmacother2005;39(2):319–28.
5.
LaubscherTEvansCBlackburnD. Collaboration between family physicians and community pharmacists to enhance adherence to chronic medications: opinions of Saskatchewan family physicians. Can Fam Physician2009;55(12):e69–75.
6.
BryantLJMCosterGGambleGDMcCormickRN. General practitioners' and pharmacists' perceptions of the role of community pharmacists in delivering clinical services. Res Soc Adm Pharm2009;5(4):347–62.
7.
HeplerCDStrandLM. Opportunities and responsibilities in pharmaceutical care. Am J Pharm Educ1989;53:7S–15S.
8.
EvansCDEurichDTTaylorJG. A pragmatic cluster randomized trial evaluating the impact of a community pharmacy intervention on statin adherence: rationale and design of the Community Pharmacy Assisting in Total Cardiovascular Health (CPATCH) study. Trials2010;11:76.
9.
AT Kearny Inc. Activity Based Costing (ABC) Study.Final report (electronic): study findings and analysis. Prepared for the BC Pharmacy Association, BC Ministry of Health Services and the Canadian Association of Chain Stores, 2007. Available: www.health.gov.bc.ca/pharmacare/ABC_Report_2007.pdf (accessed April 20, 2011).
10.
SchedlbauerADaviesPFaheyT. Interventions to improve adherence to lipid lowering medication. Cochrane Database Syst Rev2010;3:CD004371.